AstraZeneca antibody cocktail fails to prevent COVID-19, in small setback
AstraZeneca said Tuesday that a late-stage trial failed to provide evidence that its COVID-19 antibody therapy protected people who had contact with an infected person from the disease, a small setback in its efforts to find alternatives to vaccines.
Video transcript
[MUSIC PLAYING]